Randomized Controlled Trial
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 21, 2014; 20(43): 16318-16322
Published online Nov 21, 2014. doi: 10.3748/wjg.v20.i43.16318
Figure 1
Figure 1 Study design. After endoscopic submucosal dissection, all patients were randomized to 2 wk (2W) or 4 wk (4W) group. They were administered an intravenous infusion of omeprazole 20 mg every 12 h for 1 d, and received oral esomeprazole (20 mg/d) for 2 wk or 4 wk and rebamipide at a dose of 300 mg orally, 3 times a day for 4 wk. ESD: Endoscopic submucosal dissection; PPI div: Drip intravenous infusion of proton pump inhibitor (omeprazole 40 mg/d); GS: Gastroendoscopy.